News

The European Commission has approved Datroway (datopotamab deruxtecan) as a first-line treatment for adults with unresectable or metastatic triple-negative breast cancer (TNBC) who are…
Read More...

miRecule has entered into a strategic research collaboration with Rio Biofarma Brasil Ltda. (RBBL), part of Brazilian pharmaceutical company EMS S.A., to develop peptide-mediated…
Read More...

Pfizer has reported positive topline results from two Phase 3 trials evaluating LITFULO (ritlecitinib) in patients with nonsegmental vitiligo (NSV), supporting the company’s plans to…
Read More...

Resilience has expanded its strategic manufacturing partnership with Eli Lilly and Company through a combined $750 million investment aimed at increasing US production of critical…
Read More...

AbCellera and Vertex Pharmaceuticals have entered into a collaboration to research, develop, manufacture and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases…
Read More...

EVERSANA has been selected by Tokyo-based biotechnology company Innovacell Inc. as its exclusive commercialization partner in the United States, a move aimed at supporting the…
Read More...

Taisho Pharmaceutical has secured exclusive rights to develop, register and commercialize Kaigene’s KG006, a next-generation FcRn inhibitor, in Japan under a new licensing agreement…
Read More...

DKSH Business Unit Healthcare has expanded its prescription drug business in South Korea through a new strategic partnership with Novartis, adding the hypertension medicines Diovan and…
Read More...

Ember LifeSciences has entered into a capital and business alliance with Alfresa Corporation to strengthen pharmaceutical cold chain logistics in Japan and expand access to advanced…
Read More...

Shionogi has announced the US availability of XOCOVA (ensitrelvir), an oral antiviral approved by the US Food and Drug Administration (FDA) for post-exposure prophylaxis (PEP) of…
Read More...

argenx has agreed to acquire Forte Biosciences for approximately $2.2 billion in cash, strengthening its immunology pipeline with a promising experimental therapy for autoimmune…
Read More...

BioMarin Pharmaceutical and the n-Lorem Foundation have entered a strategic collaboration to develop what could become the first disease-modifying treatment for ReNU syndrome, a rare…
Read More...

Pfizer Japan Inc. and Eisai Co., Ltd. have announced a new collaboration to co-promote the migraine treatment Nurtec OD Tablet 75mg (rimegepant sulfate hydrate) across Japan beginning…
Read More...

Biointron Biological USA Inc. has introduced RushData, a new integrated service platform designed to accelerate antibody discovery by providing rapid experimental validation for…
Read More...

Outlook Therapeutics has secured U.S. Food and Drug Administration (FDA) approval for LYTENAVA™ (bevacizumab-vikg), making it the first and only FDA-approved ophthalmic formulation of…
Read More...

Bora Pharmaceuticals and South Korea-based Onconic Therapeutics have entered into a manufacturing agreement to support the U.S. clinical development of JAQBO, an investigational…
Read More...

Lundbeck has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Lu AH69593, its investigational oral orexin 2 receptor agonist being developed to treat…
Read More...

Affinia Therapeutics has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for its investigational gene therapy AFTX-201, marking another regulatory…
Read More...

BeOne Medicines has announced a $300 million investment to expand its flagship manufacturing and research facility in Hopewell, New Jersey, strengthening its U.S. production…
Read More...

Kairos Pharma has announced a strategic collaboration with Bayer to evaluate a new combination treatment approach for metastatic castration-resistant prostate cancer (mCRPC) that has…
Read More...